PharmaBio Corporation
Latest round
- Series B
Last raised
- Jan 2018
Total raised
- $5M
Investors
- 2
About PharmaBio Corporation
Founded in 1978, PharmaBio Corporation is a Tokyo-based company that develops and manufactures regenerative medicine products.PharmaBio Corporation specializes in advanced therapies, focusing primarily on the development and manufacturing of regenerative medicine and cell-based therapies. Their core offerings include comprehensive regulatory support for the development of cell and tissue-derived pharmaceuticals, as well as contract development and manufacturing organization (CDMO) services compatible with Good Cell Therapy Practices (GCTP). The company's facilities are designed to support the production of regenerative medicine products, allowing clients to harness innovative treatments for a range of medical conditions, including age-related macular degeneration and other degenerative diseases.PharmaBio's revenue model is primarily structured around contract manufacturing and development services, where clients engage the company to produce customized regenerative medicine products. These transactions are typically executed on a B2B basis, with clients including biotech firms and academic institutions seeking expertise in advanced therapeutic manufacturing. The pricing structure is based on the specific services rendered and the scale of production required, with clients entering into contracts that detail the scope of work, timelines, and deliverables. Signature offerings, such as the production of mesenchymal stem cell sheets for clinical trials, are integral to these transactions.000 mn from Alfresa Corporation for a minority stake, which will support its strategic initiatives, including the expansion of its product line and entry into new markets. The company plans to introduce new regenerative medicine products aimed at treating various medical conditions, although specific release dates are not yet disclosed. Additionally, it aims to expand its operations into broader Asian markets to enhance its reach and service offering.
Who invested in PharmaBio Corporation
2 investors across 1 round
See all investors in PharmaBio Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 8, 2018
Amount
$5M
Investors
Questions about PharmaBio Corporation
Who invested in PharmaBio Corporation?
PharmaBio Corporation has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PharmaBio Corporation raised?
PharmaBio Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PharmaBio Corporation last raise money?
PharmaBio Corporation's most recent round on record is a Series B, in Jan 2018.
What does PharmaBio Corporation do?
Founded in 1978, PharmaBio Corporation is a Tokyo-based company that develops and manufactures regenerative medicine products.
Where is PharmaBio Corporation headquartered?
PharmaBio Corporation is headquartered in Tokyo, Japan.
Which VCs invest in companies like PharmaBio Corporation?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at PharmaBio Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like PharmaBio Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.